I contribute nearly 30 years of experience in pharmaceutical product development. For the past 20 years, my primary focus has been in the design and management of a wide variety of global, clinical research and commercialization programs, such as observational research studies and patient registries. The programs helped to expand physician and patient access to new, innovative drug products by optimizing the receptivity, adoption, and long-term acceptance of novel health solutions. My prior positions include leadership roles with PAREXEL International, Abt BioPharma Solutions, Inc., and the Genzyme Corporation. I am a contributing author to Registries for Evaluating Patient Outcomes, sponsored by the Agency for Healthcare Research and Quality, and to the International Society for Pharmacoeconomics and Outcomes Research Taxonomy of Patient Registries: Classification, Characteristics and Terms, as well as have been a featured speaker at a number of conferences on observational research study design, and implementation.
I have had the good fortune to work for several leading biopharmaceutical and clinical research organizations and am continually amazed by the advances in medical research. My primary career direction, however, is rooted in a public health view toward making these scientific advances more accessible to patients with unmet medical needs. In this capacity, I have met culturally diverse physicians from around the world who share one common mission – to improve the lives of their patients. I believe this perspective helps me to understand the personal stake many researchers, physicians, and patients have in facilitating the success of new treatments. I would welcome the opportunity to work with you and to contribute to that success.
I received a B.S. degree in Pharmacy from the University of Kentucky and a M.S. degree in Health Policy and Management from the Harvard University School of Public Health.